SHATARRA SALLEY: Open Payments
NPI 1639795859 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 17 payments from 9 companies in 2025. Trend: 2023 $265 · 2024 $1,091 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Vanda Pharmaceuticals Inc. | 1 | $70 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ABBVIE INC. | 3 | $44 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: TRINTELLIX, FANAPT, Auvelity, REXULTI, VRAYLAR, Subvenite, Qelbree, Dyanavel XR.
Industry payments across SC — which companies pay providers there.
